(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are POXEL, FERMENTALG, and MAAT PHARMA.
Financial Asset | Price | Change | Updated (EST) |
---|---|---|---|
POXEL (POXEL.PA) | 0.56 | 44.42% | 2024-01-22 13:21:28 |
FERMENTALG (FALG.PA) | 0.44 | 31.85% | 2024-01-22 13:03:15 |
MAAT PHARMA (MAAT.PA) | 7.20 | 10.43% | 2024-01-22 13:05:42 |
PROTECTOR FORSIKRG (PROT.OL) | 194.60 | 9.57% | 2024-01-22 12:42:18 |
ATOS (ATO.PA) | 3.70 | 8.48% | 2024-01-22 12:45:39 |
LECTRA (LSS.PA) | 32.65 | 8.29% | 2024-01-22 13:05:23 |
GENFIT (GNFT.PA) | 3.40 | 8.29% | 2024-01-22 13:04:00 |
WAGA ENERGY (WAGA.PA) | 26.75 | 8.08% | 2024-01-22 13:24:36 |
NYXOAH (NYXH.BR) | 4.20 | 7.69% | 2024-01-22 12:20:55 |
BW OFFSHORE LTD (BWO.OL) | 24.42 | 7.48% | 2024-01-22 12:25:11 |
The three biggest losers today are POLIGHT, SERGEFERRARI GROUP, and IEX GROUP NV.
Financial Asset | Price | Change | Updated (EST) |
---|---|---|---|
POLIGHT (PLT.OL) | 22.35 | -8.21% | 2024-01-22 12:42:14 |
SERGEFERRARI GROUP (SEFER.PA) | 6.70 | -7.46% | 2024-01-22 13:22:32 |
IEX GROUP NV (IEX.AS) | 1.60 | -6.98% | 2024-01-22 12:02:24 |
CARASENT (CARA.OL) | 11.50 | -6.5% | 2024-01-22 12:25:17 |
NX FILTRATION (NXFIL.AS) | 4.61 | -6.49% | 2024-01-22 12:03:02 |
JCDECAUX (DEC.PA) | 17.06 | -6.06% | 2024-01-22 13:05:05 |
IMPRESA,SGPS (IPR.LS) | 0.15 | -5.99% | 2024-01-22 12:23:20 |
KOMPLETT (KOMPL.OL) | 10.66 | -5.66% | 2024-01-22 12:40:52 |
CNOVA (CNV.PA) | 1.70 | -5.56% | 2024-01-22 13:01:14 |
FRANCAISE ENERGIE (FDE.PA) | 45.25 | -5.43% | 2024-01-22 13:03:47 |
Winners today
1. POXEL (POXEL.PA)
44.42% Price Change
Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan. It also develops PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in a Phase 2a clinical trial that treats chronic metabolic diseases, including diseases that affect the liver, such as non-alcoholic steatohepatitis (NASH); PXL065, an earlier stage programs that is in Phase 2 for the treatment of NASH focusing on chronic and rare metabolic indications. The company has a licensing agreement with Enyo Pharma S.A.S. for the development of farnesoid X receptor that is in Phase 2a study for the treatment of hepatitis B and NASH; and DeuteRx LLC for the development of PXL065, a mitochondrial pyruvate carrier inhibitor, which is in a phase I clinical trial for the treatment of NASH. Poxel S.A. was incorporated in 2009 and is headquartered in Lyon, France.
CAC 40 ended the session with POXEL jumping 44.42% to €0.56 on Monday while CAC 40 jumped 0.56% to €7,413.25.
Earnings Per Share
As for profitability, POXEL has a trailing twelve months EPS of €-1.08.
More news about POXEL.
2. FERMENTALG (FALG.PA)
31.85% Price Change
Fermentalg SA develops, produces, and sells active ingredients extracted from microalgae for the food, health, nutrition, and environment sectors in France and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; BLUE ORIGIN, a natural color; and environmental and clean air solutions that captures CO2 in industries. The company was incorporated in 2009 and is headquartered in Libourne, France.
CAC 40 ended the session with FERMENTALG rising 31.85% to €0.44 on Monday while CAC 40 jumped 0.56% to €7,413.25.
Earnings Per Share
As for profitability, FERMENTALG has a trailing twelve months EPS of €-0.24.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.52%.
More news about FERMENTALG.
3. MAAT PHARMA (MAAT.PA)
10.43% Price Change
MaaT Pharma SA, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors. Its products pipeline includes MaaT013 that has completed phase 2 clinical trials for the treatment of acute graft versus host diseases, as well as in preclinical trials to treat melanoma; MaaT033, which is in phase 1b clinical trials for the improvement of survival in patients with acute myeloid leukemia or other liquid tumors receiving allogeneic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors. The company was incorporated in 2014 and is headquartered in Lyon, France.
CAC 40 ended the session with MAAT PHARMA jumping 10.43% to €7.20 on Monday while CAC 40 rose 0.56% to €7,413.25.
Earnings Per Share
As for profitability, MAAT PHARMA has a trailing twelve months EPS of €-1.4.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -46.11%.
Volatility
MAAT PHARMA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.41%, a negative 0.43%, and a positive 3.28%.
MAAT PHARMA’s highest amplitude of average volatility was 2.41% (last week), 2.90% (last month), and 3.28% (last quarter).
Moving Average
MAAT PHARMA’s worth is way above its 50-day moving average of €6.11 and under its 200-day moving average of €7.83.
Volume
Today’s last reported volume for MAAT PHARMA is 2952 which is 92.81% above its average volume of 1531.
Revenue Growth
Year-on-year quarterly revenue growth grew by 178.9%, now sitting on 2.31M for the twelve trailing months.
More news about MAAT PHARMA.
4. PROTECTOR FORSIKRG (PROT.OL)
9.57% Price Change
Protector Forsikring ASA, a general insurance company, provides various insurance products to the commercial and public sectors, and the affinity insurance markets in Norway, Denmark, Sweden, the United Kingdom, and Finland. It operates in Commercial Lines of Business and Public Lines of Business segments. The company offers personal, motor, property, liability, and change of ownership insurance. It sells its products to non-marine industries through insurance brokers. Protector Forsikring ASA was founded in 2003 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with PROTECTOR FORSIKRG rising 9.57% to €194.60 on Monday, after three successive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.02% to €1,278.24, after two successive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, PROTECTOR FORSIKRG has a trailing twelve months EPS of kr10.66.
PE Ratio
PROTECTOR FORSIKRG has a trailing twelve months price to earnings ratio of 18.26. Meaning, the purchaser of the share is investing kr18.26 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.4%.
Volume
Today’s last reported volume for PROTECTOR FORSIKRG is 153500 which is 81.89% above its average volume of 84390.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, PROTECTOR FORSIKRG’s stock is considered to be overbought (>=80).
Revenue Growth
Year-on-year quarterly revenue growth grew by 30%, now sitting on 8.2B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 46.6% and a negative 61.3%, respectively.
More news about PROTECTOR FORSIKRG.
5. ATOS (ATO.PA)
8.48% Price Change
Atos SE provides digital transformation solutions and services worldwide. It offers advanced computing solutions; analytics, artificial intelligence, and automation solutions; cloud solutions; customer journey analytics and digital customer experience; decarbonization solutions; digital consulting; digital workplace solutions; edge computing and Internet of things solutions; and modern applications and platforms. The company also provides advance detection and response, data protection and governance, digital workplace security, IoT and OT security, trusted digital identities, and cybersecurity solutions; and infrastructure and foundation services. It serves financial services and insurance, healthcare and life sciences, manufacturing, public sector and defense, resources and services, telecom, media, and entertainment industries. The company was incorporated in 1982 and is headquartered in Bezons, France.
CAC 40 ended the session with ATOS rising 8.48% to €3.70 on Monday while CAC 40 rose 0.56% to €7,413.25.
Earnings Per Share
As for profitability, ATOS has a trailing twelve months EPS of €-10.01.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ATOS’s stock is considered to be overbought (>=80).
Volatility
ATOS’s last week, last month’s, and last quarter’s current intraday variation average was a negative 5.04%, a negative 4.57%, and a positive 4.24%.
ATOS’s highest amplitude of average volatility was 7.52% (last week), 5.51% (last month), and 4.24% (last quarter).
More news about ATOS.
6. LECTRA (LSS.PA)
8.29% Price Change
Lectra SA provides industrial intelligence solutions for fashion, automotive, and furniture markets. The company's solutions include software, automated cutting equipment, data, and related services, which enable customers to automate and optimize product design, development, and manufacture of garments, car seats and interiors, airbags, and sofas, as well as to digitalize their processes. It also offers technical maintenance, support, training, and consulting services; and sells consumables and parts. The company operates in Europe, the Americas, the Asia-Pacific, and internationally. Lectra SA was incorporated in 1973 and is headquartered in Paris, France.
CAC 40 ended the session with LECTRA jumping 8.29% to €32.65 on Monday, following the last session’s upward trend. CAC 40 rose 0.56% to €7,413.25, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, LECTRA has a trailing twelve months EPS of €0.91.
PE Ratio
LECTRA has a trailing twelve months price to earnings ratio of 35.88. Meaning, the purchaser of the share is investing €35.88 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.4%.
Sales Growth
LECTRA’s sales growth is 0.3% for the present quarter and 2.2% for the next.
Revenue Growth
Year-on-year quarterly revenue growth declined by 16%, now sitting on 488.12M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, LECTRA’s stock is considered to be overbought (>=80).
More news about LECTRA.
7. GENFIT (GNFT.PA)
8.29% Price Change
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company develops Elafibranor, which is in Phase III clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; VS-01 for the treatment of Urea Cycle Disorder (UCD) and Organic Acidemia Disorder (OAD); GNS561, which is in Phase 1b/2 trial to treat patients with cholangiocarcinoma (CCA); and VS-01-ACLF and Nitazoxanide (NTZ), which is in Phase 1 trial to treat acute-on-chronic liver failure, as well as VS-02-HE, which is in preclinical trial for the treatment of Reduction of Hyperammonemia and the Stabilization of Blood Ammonia. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. The company was incorporated in 1999 and is headquartered in Loos, France.
CAC 40 ended the session with GENFIT jumping 8.29% to €3.40 on Monday, after five consecutive sessions in a row of losses. CAC 40 jumped 0.56% to €7,413.25, following the last session’s downward trend on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, GENFIT has a trailing twelve months EPS of €-0.68.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.21%.
Yearly Top and Bottom Value
GENFIT’s stock is valued at €3.40 at 21:40 EST, way under its 52-week high of €4.92 and way higher than its 52-week low of €2.84.
Revenue Growth
Year-on-year quarterly revenue growth grew by 24.5%, now sitting on 29.22M for the twelve trailing months.
Volume
Today’s last reported volume for GENFIT is 447899 which is 73.48% above its average volume of 258180.
Volatility
GENFIT’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.60%, a negative 0.64%, and a positive 2.01%.
GENFIT’s highest amplitude of average volatility was 1.60% (last week), 1.71% (last month), and 2.01% (last quarter).
More news about GENFIT.
8. WAGA ENERGY (WAGA.PA)
8.08% Price Change
Waga Energy Société anonyme, together with its subsidiaries, develops biomethane injections projects serving the energy transitions. It is involved in the design, development, financing, construction, installation, and exploitation solutions, as well as sale of biomethane. The company was incorporated in 2015 and is headquartered in Meylan, France.
CAC 40 ended the session with WAGA ENERGY jumping 8.08% to €26.75 on Monday while CAC 40 jumped 0.56% to €7,413.25.
Earnings Per Share
As for profitability, WAGA ENERGY has a trailing twelve months EPS of €-0.63.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.43%.
Yearly Top and Bottom Value
WAGA ENERGY’s stock is valued at €26.75 at 21:40 EST, way under its 52-week high of €31.80 and way higher than its 52-week low of €20.00.
Moving Average
WAGA ENERGY’s value is higher than its 50-day moving average of €26.16 and higher than its 200-day moving average of €26.20.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, WAGA ENERGY’s stock is considered to be oversold (<=20).
Revenue Growth
Year-on-year quarterly revenue growth grew by 72.1%, now sitting on 19.16M for the twelve trailing months.
More news about WAGA ENERGY.
9. NYXOAH (NYXH.BR)
7.69% Price Change
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
BEL 20 ended the session with NYXOAH rising 7.69% to €4.20 on Monday, following the last session’s upward trend. BEL 20 jumped 1.02% to €3,592.87, following the last session’s upward trend on what was an all-around up trend trading session today.
Earnings Per Share
As for profitability, NYXOAH has a trailing twelve months EPS of €-1.68.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.76%.
More news about NYXOAH.
10. BW OFFSHORE LTD (BWO.OL)
7.48% Price Change
BW Offshore Limited engages in the engineering of offshore production solutions in the Americas, Europe, Africa, Asia, and the Pacific. The company builds, owns, leases, and operates floating, production, storage, and offloading vessels (FPSOs) for oil and gas industries. It also provides engineering services. The company was founded in 1982 and is based in Hamilton, Bermuda.
Oslo Børs Benchmark Index_GI ended the session with BW OFFSHORE LTD rising 7.48% to €24.42 on Monday, after two sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 0.02% to €1,278.24, after two consecutive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, BW OFFSHORE LTD has a trailing twelve months EPS of kr5.57.
PE Ratio
BW OFFSHORE LTD has a trailing twelve months price to earnings ratio of 4.38. Meaning, the purchaser of the share is investing kr4.38 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.08%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BW OFFSHORE LTD’s stock is considered to be oversold (<=20).
Moving Average
BW OFFSHORE LTD’s worth is below its 50-day moving average of kr26.84 and below its 200-day moving average of kr27.05.
Sales Growth
BW OFFSHORE LTD’s sales growth is negative 36.8% for the present quarter and negative 31% for the next.
More news about BW OFFSHORE LTD.
Losers Today
1. POLIGHT (PLT.OL)
-8.21% Price Change
poLight ASA develops optical lens for consumer devices and industrial applications in Europe, Asia, and the United States. The company's lens replicates the lens of the human eye enabling the implementation of autofocus functions for various applications. Its product portfolio includes TLens, a tuneable optical lens for autofocus camera applications; Packaged TLens that facilitates integration of a TLens on a fixed-focus camera module; ASIC drivers, which control the supply of variable voltage to Tlens products and makes them to change focus; TLens Silver and TLens Silver Premium devices; and evaluation kits that allows to test and evaluate the optical and electrical performance of the TLens in new products and/or applications. it serves smartphones and wearables, barcode/industrial, augmented reality, medical endoscopy, webcams, and other markets. poLight ASA was founded in 2005 and is headquartered in Skoppum, Norway.
Oslo Børs Benchmark Index_GI ended the session with POLIGHT sliding 8.21% to €22.35 on Monday, after four successive sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 0.02% to €1,278.24, after two successive sessions in a row of gains, on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, POLIGHT has a trailing twelve months EPS of kr-1.2.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -38.27%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
POLIGHT’s EBITDA is -39.19.
More news about POLIGHT.
2. SERGEFERRARI GROUP (SEFER.PA)
-7.46% Price Change
SergeFerrari Group SA designs, develops, manufactures, and markets composite materials for lightweight architectural and outdoor applications in France and internationally. It provides its products for solar protection, tensile architecture, modular structures, and furniture/marine markets. The company offers solutions for indoor and outdoor blind, and terrace blind and awning; tensile roof and shading structure; indoor and outdoor acoustic treatment; bioclimatic façade, including building construction and renovation; and waterproof breathable membrane applications. It also provides products and solutions for modular structure, visual communication for printed advertisement, protection, environment, and yachting applications. In addition, the company offers outdoor sling seats and membranes for garden furniture; and upholstery for indoor and outdoor furniture. The company was founded in 1973 and is headquartered in Saint-Jean-de-Soudain, France.
CAC 40 ended the session with SERGEFERRARI GROUP dropping 7.46% to €6.70 on Monday, after five sequential sessions in a row of losses. CAC 40 rose 0.56% to €7,413.25, following the last session’s downward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, SERGEFERRARI GROUP has a trailing twelve months EPS of €0.88.
PE Ratio
SERGEFERRARI GROUP has a trailing twelve months price to earnings ratio of 7.61. Meaning, the purchaser of the share is investing €7.61 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.9%.
Yearly Top and Bottom Value
SERGEFERRARI GROUP’s stock is valued at €6.70 at 21:40 EST, way under its 52-week high of €16.00 and way higher than its 52-week low of €5.23.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SERGEFERRARI GROUP’s stock is considered to be overbought (>=80).
More news about SERGEFERRARI GROUP.
3. IEX GROUP NV (IEX.AS)
-6.98% Price Change
IEX Group N.V., through its subsidiaries, operates financial websites in the Netherlands and Belgium. It operates Beurs.nl, Belegger.nl, Beleggen.nl, DeBeurs.nl, Beursonline.nl, Participaties.nl, Beursgorilla.nl, Tostrams.nl and Guruwatch websites. The company also provides investment information services. In addition, the company offers IEX Expert and IEX Profs magazine for various investors; and organizes various events for private individuals and professionals. IEX Group N.V. was founded in 1999 and is based in Amsterdam, the Netherlands.
AEX-Index ended the session with IEX GROUP NV dropping 6.98% to €1.60 on Monday, after five consecutive sessions in a row of losses. AEX-Index rose 0.86% to €785.60, after two successive sessions in a row of gains, on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, IEX GROUP NV has a trailing twelve months EPS of €0.25.
PE Ratio
IEX GROUP NV has a trailing twelve months price to earnings ratio of 6.4. Meaning, the purchaser of the share is investing €6.4 for every euro of annual earnings.
Moving Average
IEX GROUP NV’s worth is under its 50-day moving average of €1.76 and way under its 200-day moving average of €1.79.
Yearly Top and Bottom Value
IEX GROUP NV’s stock is valued at €1.60 at 21:40 EST, under its 52-week low of €1.60.
More news about IEX GROUP NV.
4. CARASENT (CARA.OL)
-6.5% Price Change
Carasent ASA provides cloud-based medical record services to the health care industry in the Nordic region. The company offers Webdoc, a digital electronic health record (EHR) system; Vårdrummet, a digital platform for communication between patients and therapists, as well as care givers; and Ad Curis, a journal and professional system that delivers forward-thinking services to rehabilitation, substance abuse treatment, and mental health care, as well as organizations within upbringing and preventive works. It also provides Metodika EPM, a solution for medium sized private clinics and hospitals; Medrave M4, a program that offers healthcare professionals with an overview of the patient treatment group; Confrere, a video solution for physicians; and Plustoo, a software solution that collects, analyses, and visualizes data, as well as enables occupational health providers, employers, and employees to collaborate for healthy and sustainable work environment. In addition, the company provides Ad Voca; and Ad Opus, a system that structures work processes to follow-up participants in a course of measures for companies that work with inclusion into working life. Carasent ASA was formerly known as Apptix ASA and changed its name to Carasent ASA in May 2019. The company was founded in 1997 and is based in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with CARASENT dropping 6.5% to €11.50 on Monday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 0.02% to €1,278.24, after two consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, CARASENT has a trailing twelve months EPS of kr-0.8.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.05%.
Moving Average
CARASENT’s worth is way under its 50-day moving average of kr15.55 and way under its 200-day moving average of kr16.10.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 62.5% and a negative 83.3%, respectively.
Sales Growth
CARASENT’s sales growth is 32.3% for the ongoing quarter and 19.4% for the next.
More news about CARASENT.
5. NX FILTRATION (NXFIL.AS)
-6.49% Price Change
NX Filtration N.V. develops, manufactures, and sells hollow fiber membrane solutions for treating water and other liquids in the Netherlands, rest of Europe, North America, Asia, and internationally. The company offers direct nanofiltration, ultrafiltration, and microfiltration membrane modules that remove bacteria, viruses, micropollutants, color, nano plastics, and selective salts from water without pre-treatment and use of chemicals. It also provides HYDRAcap ultrafiltration modules to treat surface water, ground water, seawater, and wastewaters as primary treatment or pretreatment to reverse osmosis and nanofiltration. The company was incorporated in 2016 and is headquartered in Enschede, the Netherlands.
AEX-Index ended the session with NX FILTRATION dropping 6.49% to €4.61 on Monday while AEX-Index jumped 0.86% to €785.60.
Earnings Per Share
As for profitability, NX FILTRATION has a trailing twelve months EPS of €-0.12.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.69%.
Volatility
NX FILTRATION’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.69%, a negative 1.73%, and a positive 2.61%.
NX FILTRATION’s highest amplitude of average volatility was 3.69% (last week), 3.38% (last month), and 2.61% (last quarter).
Moving Average
NX FILTRATION’s value is way under its 50-day moving average of €6.19 and way under its 200-day moving average of €8.52.
More news about NX FILTRATION.
6. JCDECAUX (DEC.PA)
-6.06% Price Change
JCDecaux SE engages in the outdoor advertising activities worldwide. It operates through three segments: Street Furniture, Transport, and Billboard. The Street Furniture segment is involved in advertising in shopping malls; renting of street furniture; selling and renting of equipment; and the provision of cleaning, maintenance, and other activities. The Transport segment provides advertising services in public transport systems, such as airports, metros, buses, trams, and trains. The Billboard segment is involved in advertising on private property, including traditional large format or back-light billboards; neon-light billboards; and advertising wall wraps. The company was founded in 1964 and is based in Neuilly-sur-Seine, France. JCDecaux SE is a subsidiary of JCDecaux Holding SAS.
CAC 40 ended the session with JCDECAUX sliding 6.06% to €17.06 on Monday while CAC 40 rose 0.56% to €7,413.25.
Earnings Per Share
As for profitability, JCDECAUX has a trailing twelve months EPS of €0.85.
PE Ratio
JCDECAUX has a trailing twelve months price to earnings ratio of 20.07. Meaning, the purchaser of the share is investing €20.07 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.12%.
More news about JCDECAUX.
7. IMPRESA,SGPS (IPR.LS)
-5.99% Price Change
Impresa – Sociedade Gestora de Participações Sociais, S.A., through its subsidiaries, operates in the media industry in Portugal and internationally. The company operates through Television, Publishing, and Others segments. The Television segment broadcasts SIC, SIC Notícias, SIC Radical, SIC Internacional, SIC Mulher, SIC K, and SIC Caras television channels in open signal and by cable under broadcasting licenses. The Publishing segment publishes Expresso, a weekly newspaper; and newspapers, books, and other publications. The Others segment operates in geographic information systems area. It also offers multimedia production, rendering, and real estate management and related services, as well as Olhares, a photography website. Impresa – Sociedade Gestora de Participações Sociais, S.A. was founded in 1972 and is headquartered in Paço De Arcos, Portugal.
PSI ended the session with IMPRESA,SGPS sliding 5.99% to €0.15 on Monday while PSI jumped 0.35% to €6,335.69.
Yearly Top and Bottom Value
IMPRESA,SGPS’s stock is valued at €0.15 at 21:40 EST, way under its 52-week high of €0.21 and higher than its 52-week low of €0.15.
Sales Growth
IMPRESA,SGPS’s sales growth is negative 12.3% for the ongoing quarter and negative 12.3% for the next.
Revenue Growth
Year-on-year quarterly revenue growth declined by 2.5%, now sitting on 182.96M for the twelve trailing months.
Volatility
IMPRESA,SGPS’s last week, last month’s, and last quarter’s current intraday variation average was 1.98%, 0.48%, and 1.42%.
IMPRESA,SGPS’s highest amplitude of average volatility was 4.51% (last week), 2.79% (last month), and 1.42% (last quarter).
More news about IMPRESA,SGPS.
8. KOMPLETT (KOMPL.OL)
-5.66% Price Change
Komplett ASA operates as an online retailer of electronics and IT products in Norway, Sweden, and Denmark. The company operates through three segments: Business to Consumer (B2C), Business to Business (B2B), and Distribution. It offers consumer electronics and business solutions, including computer components, gaming, PCs, household electronics, and other computer-related products, as well as brown and white goods, and cloud-based IT solutions and services. It operates webshops under the Komplett brand; and retail stores under the Webhallen brand. The company's B2B operations include sales to companies and public entities/institutions under the Komplett Bedrift and Komplett Företag. It also distributes products to resellers and other entities under the Itegra brand. The company was formerly known as Norkom ASA and changed its name to Komplett ASA in December 2002. Komplett ASA was founded in 1991 and is headquartered in Sandefjord, Norway.
Oslo Børs Benchmark Index_GI ended the session with KOMPLETT dropping 5.66% to €10.66 on Monday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 0.02% to €1,278.24, after two consecutive sessions in a row of gains, on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, KOMPLETT has a trailing twelve months EPS of kr-1.51.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.19%.
Moving Average
KOMPLETT’s value is way higher than its 50-day moving average of kr8.82 and below its 200-day moving average of kr11.38.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, KOMPLETT’s stock is considered to be oversold (<=20).
Volatility
KOMPLETT’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.14%, a negative 0.14%, and a positive 3.51%.
KOMPLETT’s highest amplitude of average volatility was 3.17% (last week), 2.65% (last month), and 3.51% (last quarter).
More news about KOMPLETT.
9. CNOVA (CNV.PA)
-5.56% Price Change
Cnova N.V. operates as an e-commerce company in France and Western Europe. The company offers home appliances, consumer electronics, computers, home furnishings, and leisure and personal goods through its cdiscount.com website. It also operates Cdiscount Voyages, a travel platform; Cdiscount Mobile for cell phone plans; Cdiscount Advertising, a digital marketing solution; Octopia for turnkey marketplace solutions to retailers and e-merchants; and C-Logistics for transportation and logistics services. The company was founded in 1998 and is headquartered in Amsterdam, the Netherlands. Cnova N.V. is a subsidiary of Casino, Guichard-Perrachon S.A.
CAC 40 ended the session with CNOVA falling 5.56% to €1.70 on Monday while CAC 40 jumped 0.56% to €7,413.25.
Earnings Per Share
As for profitability, CNOVA has a trailing twelve months EPS of €-0.35.
Volume
Today’s last reported volume for CNOVA is 81 which is 89.97% below its average volume of 808.
Yearly Top and Bottom Value
CNOVA’s stock is valued at €1.70 at 21:40 EST, way below its 52-week high of €4.97 and way higher than its 52-week low of €1.20.
More news about CNOVA.
10. FRANCAISE ENERGIE (FDE.PA)
-5.43% Price Change
La Française de l'Energie S.A., together with its subsidiaries, operates as a carbon-negative energy production company in France. It engages in the generation of electricity and heat though photovoltaic plants; purification and liquefaction of biogas, landfill gas, flare gas, rare gases, etc.; and production of bio liquefied natural gas, carbon dioxide, and hydrogen. The company was founded in 2006 and is headquartered in Faulquemont, France.
CAC 40 ended the session with FRANCAISE ENERGIE dropping 5.43% to €45.25 on Monday while CAC 40 jumped 0.56% to €7,413.25.
Earnings Per Share
As for profitability, FRANCAISE ENERGIE has a trailing twelve months EPS of €2.31.
PE Ratio
FRANCAISE ENERGIE has a trailing twelve months price to earnings ratio of 19.59. Meaning, the purchaser of the share is investing €19.59 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.3%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.5%, now sitting on 39.23M for the twelve trailing months.
More news about FRANCAISE ENERGIE.
Stay up to date with our winners and losers daily report